GLE secures exclusive offtake with Cameco for 100% of planned Paducah enrichment facility output
Silex Systems (ASX: SLX) has announced that its 51%-owned subsidiary, Global Laser Enrichment (GLE), has executed an exclusive Offtake Agreement with Cameco Corporation under which Cameco will purchase all of the future production from GLE’s planned Paducah Laser Enrichment Facility (PLEF) in Kentucky. GLE is the exclusive licensee of the SILEX uranium enrichment technology. The agreement represents a significant commercial milestone on the path toward a future Final Investment Decision (FID) for the facility.
When big ASX news breaks, our subscribers know first
What the offtake agreement delivers
Under the terms of the exclusive Offtake Agreement, Cameco will buy all of the future production of GLE’s nuclear fuel output from the PLEF. The pricing structure is designed to provide GLE with direct exposure to market-rate returns without requiring the company to build its own commercial sales infrastructure.
Specifically, GLE will receive pricing for its products equivalent to Cameco’s average realised price, net of appropriate selling costs, achieved on an annual basis across Cameco’s long-term contracting portfolio. This arrangement removes the need for GLE to establish its own sales and marketing resources, a significant cost that would otherwise weigh on the project’s economics ahead of full commercial operation.
Michael Goldsworthy, CEO/Managing Director, Silex Systems
“We are delighted with the execution of this crucial Offtake Agreement which provides a home for all of GLE’s future nuclear fuel products, including natural UF6 and enriched uranium products to help fuel the world’s rapidly growing nuclear reactor fleet. The Agreement will guarantee GLE receives pricing for its products equivalent to Cameco’s average realised price, net of appropriate selling costs, achieved on an annual basis across its long-term contracting portfolio, and without the significant cost of GLE establishing its own sales and marketing resources.”
| Term | Detail |
|---|---|
| Agreement Type | Exclusive Offtake |
| Buyer | Cameco Corporation |
| Seller | GLE (51% owned by Silex Systems) |
| Scope | 100% of PLEF future production |
| Pricing Mechanism | Cameco average realised price, net of appropriate selling costs |
Products covered under the agreement
The PLEF is planned to produce a range of nuclear fuel products, all of which fall within the scope of the offtake agreement:
- Natural uranium as UF6
- Low Enriched Uranium (LEU)
- LEU+
- High-assay LEU (HALEU), intended for next-generation advanced reactors including small modular reactors (SMRs)
These products are designed to serve both the existing global reactor fleet and the growing advanced and next-generation reactor market, which has seen increasing investment globally as governments pursue clean energy and energy security objectives.
Why Cameco is the right partner and why this matters for FID
Cameco is one of the largest global providers of nuclear fuel, with a portfolio spanning uranium mining, refining, and conversion. Critically, this is not a new commercial relationship. Cameco already holds 49% ownership interests in both GLE and Westinghouse Electric Company, meaning the offtake agreement deepens an existing strategic partnership rather than introducing an unfamiliar third party into the project.
The commercial significance extends beyond revenue visibility. As Goldsworthy stated, the agreement provides “a key commercial pillar to support a future final investment decision (FID) for the PLEF.” The FID has not yet been made, and the offtake agreement is specifically cited as one of the foundational elements required to support that decision.
The PLEF funding structure already combines a US$28.5 million DOE award, approximately US$600 million in privately funded investment, and a US$98.9 million preliminary Kentucky state and local incentives package, layers of capital support that sit alongside the offtake agreement as pillars of the eventual FID case.
Michael Goldsworthy, CEO/Managing Director, Silex Systems
“Cameco is one of the largest global providers of nuclear fuel with significant investments across the nuclear industry, including 49% ownership interests in both GLE and Westinghouse Electric Company. The Agreement with Cameco also provides a key commercial pillar to support a future final investment decision (FID) for the PLEF. The Offtake Agreement contains customary contractual terms to protect the interests of GLE and Silex…”
The agreement contains customary contractual terms to protect the interests of GLE and Silex. The specific terms of those protections have not been publicly disclosed.
Understanding uranium enrichment and why offtake agreements matter for investors
Uranium enrichment is the industrial process of increasing the concentration of the uranium-235 (U-235) isotope within uranium, making it suitable for use as fuel in nuclear reactors. Natural uranium contains only about 0.7% U-235; reactor fuel typically requires concentrations of 3–5% for conventional reactors, and significantly higher levels for advanced reactor designs such as SMRs.
Enrichment capacity is a strategically sensitive link in the nuclear fuel supply chain. Russia has historically held a dominant share of global enrichment capacity, a concentration that has prompted Western governments and utilities to accelerate efforts to develop domestic and allied-nation alternatives. This context has elevated both the strategic and commercial value of new Western enrichment projects.
An offtake agreement, in simple terms, is a binding commitment from a buyer to purchase the output of a facility before that facility is built or operational. For a large capital project still in development, securing offtake from a tier-one counterparty is a fundamental commercial de-risking step. It signals to financiers, governments, and other stakeholders that a market exists for the product and that a creditworthy buyer is committed. For GLE and Silex, the relevance is direct: this agreement is framed as a prerequisite pillar for the FID, not a consequence of it.
The PLEF would use the SILEX laser-based enrichment process, a differentiated technology pathway from the centrifuge method that currently dominates global enrichment capacity. GLE holds the exclusive licence to deploy this technology commercially.
Silex’s laser enrichment platform now underpins two parallel commercialisation programs: the uranium enrichment pathway through GLE and a laser-based silicon enrichment plant in Sydney that completed construction in June 2026, with sample production of enriched silicon-28 targeted for Q1 CY2027.
Path ahead — conditions on the road to commercial production
Commercial production at the PLEF remains subject to a number of conditions that must be met before the facility moves forward. The key remaining steps, as stated in the announcement, include:
- Satisfactory completion of the SILEX technology maturation programme
- A positive feasibility assessment for the PLEF leading to an FID
- Nuclear fuel market conditions remaining supportive
- Industry and government support
- Commercial plant licensing
Subject to these factors being met, the SILEX uranium enrichment technology could become a major contributor to nuclear fuel production for the world’s current and future nuclear reactor fleets, according to the announcement.
GLE, as Silex’s 51%-owned subsidiary and holder of the exclusive offtake agreement, now has a foundational commercial pillar in place. The path to FID remains conditional, but the commercial framework underpinning that decision has taken a material step forward.
Don’t Miss the Next Energy Tech Breakthrough on ASX
Big News Blast delivers FREE breaking ASX news straight to your inbox within minutes of release, complete with in-depth analysis already done for you. Join 20,000+ subscribers who stay ahead of the market the moment announcements drop. Click the “Free Alerts” button at Big News Blast to start receiving alerts today.